• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Feeding Back Value-Based Performance Information to Physicians

Video

Value-based purchasing is built on the premise that audit providers feeding them back information on their performance has been not sufficient,” says Ateev Mehrotra, MD, MPH, associate professor of healthcare policy and medicine at Harvard Medical School and a hospitalist at Beth Israel Deaconess Medical Center. In theory, if a physician were told he or she had performed poorly on a particular measure there would be a reaction and change, but he admits this is not supported by the evidence. For some reason, “audit and feedback” does not make too much of a difference with providers.

Arthur Vercillo, MD, FACS, regional president, Excellus Blue Cross Blue Shield, does not agree that providers were not influenced when presented with value-based practice data. He believes that although they initially resist changing how they practice, “When you look at the behavior later it does change.”

According to Francois de Brantes, MS, MBA, executive director of the Healthcare Incentives Improvement Institute, providing appropriate feedback to providers is now no longer a luxury but a necessity. He cites the example of a group of orthopedic surgeons who were shown their performance data as part of a value-based purchasing program—their basic takeaway was, “All those non—evidence-based things that we knew we shouldn’t do, we finally have a reason not to do.” Mr de Brantes added that many payers have driven incentives against professionalism for decades, “and they are beginning to realize that it may not be a good idea.”


Related Videos
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
Jo Varshney, PhD, DVM, CEO and founder of VeriSIM Life
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
Adam Brufsky, MD, PhD, University of Pittsburgh
Enrique Velazquez Villarreal, MD, PhD, MPH, MS, assistant professor in the department of integrative translational sciences at City of Hope
Dr Marco Del Riccio
Dr Steven Manobianco
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.